| Literature DB >> 34303467 |
Lennart M Roesner1, Charlie Bridgewood2, Dennis McGonagle3, Miriam Wittmann4.
Abstract
The application of biologics in clinical practice allows immunological observations under real-life conditions. In a new article in the Journal of Investigative Dermatology, Bakker et al. (2021) use deep immune cell phenotyping to demonstrate how dupilumab acts in a targeted fashion on skin-homing T cells, the driver cells of atopic dermatitis.Entities:
Year: 2021 PMID： 34303467 DOI： 10.1016/j.jid.2021.02.007
Source DB: PubMed Journal: J Invest Dermatol ISSN： 0022-202X Impact factor: 8.551